Pathology News

DICOM Implementation Using the Aperio GT 450 DX Whole Slide Imaging Solution for Anatomic Pathology Case Diagnosis

December 18, 2024|Industry News, Leica Biosystems|

DICOM implementation using the Aperio GT 450 DX Whole Slide Imaging Solution for anatomic pathology case diagnosis

Digital Pathology (DP) has witnessed transformative growth in recent years, fueled by advancements in technology and an increasing need for efficient diagnostic workflows. As the adoption of whole slide imaging (WSI) systems expands, the demand for standardized, interoperable image sharing has become a critical focus for healthcare providers and researchers alike. Proprietary file formats have historically posed significant barriers to seamless collaboration and data exchange, limiting the full potential of digital pathology in clinical practice.

The Digital Imaging and Communications in Medicine (DICOM) standard, widely recognized in radiology, is now emerging as a solution to these challenges in pathology. By enabling vendor-neutral image sharing, archiving, and integration with laboratory information systems (LIS), DICOM has the potential to revolutionize diagnostic workflows and enhance patient care. The Leica Biosystems Aperio GT 450 DX Whole Slide Imaging Solution is at the forefront of this shift, as the first FDA-cleared WSI system to natively support DICOM format, offering unprecedented interoperability and paving the way for widespread adoption of this standard in digital pathology.

This article explores the importance of DICOM standardization in DP, the groundbreaking role of the Aperio GT 450 DX, and the implications of this innovation for the future of pathology.

Whitepaper Background

The digital pathology (DP) landscape has grown globally with a revenue of just under $800 million in 2021, with the initial growth attributed to the COVID-19 pandemic, which enabled the pathologist to render remote diagnosis and allowed for continued services to the patients to more than $1 billion in 2024, and projected to increase to about $2 billion by 2027 in clinical and research settings with the continuous rising trend expected to transition to the next decade. Additionally, a 15% growth in DP adoption by the healthcare community versus a minuscule initial market footprint in the last 5 years corroborates the interest shown by pathologists in using this technology. As DP use in clinical medicine increases, the easy exchange of patient information is imperative to improve patient and health management. A primary advantage of the DP system is that a pathologist can share whole slide images with colleagues in real-time. The true potential of DP can be realized if there is an unimpeded sharing of images among pathologists, irrespective of the imaging software and hardware being used.

Share this article

Follow us

Get Pathology News Delivered to Your Inbox

Learn More

Leica Biosystems logo

Leica Biosystems News

Leica Biosystems Solutions
Go to Top